Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Experientia|October 15, 1979
Reduction of acute toxicity of cyclophosphamide and X-rays by the new immunomodulating compound BM 12.531U Bicker, K D Friedberg, G Hebold, et al.Journal of Immunopharmacology|January 1, 1986
Suppression of spontaneous insulin-dependent diabetes in BB rats by administration of ciamexoneU Kiesel, K Maruta, U Treichel, et al.Cancer Treatment Reviews|September 1, 1990
In vivo antitumor activity of ilmofosineD B Herrmann, W Pahlke, H G Opitz, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1984
Treatment of autochthonous rat colonic adenocarcinomas with a thioether-lysophospholipid derivative in mono- and combination chemotherapyM E Heim, M Swoboda, W Pahlke, et al.Experimental Pathology|January 1, 1981
Influence of the immunomodulating compound BM 12.531 (azimexone) on radioresistance and granulopoietic colony forming units in miceW D Gassel, H Laukel, R Braun, et al.Lipids|November 1, 1987
Synthesis of thioether phosphocholine analoguesE Bosies, D B Herrmann, U Bicker, et al.Lipids|November 1, 1987
Pharmacokinetics of the thioether phospholipid analogue BM 41.440 in ratsD B Herrmann, E Besenfelder, U Bicker, et al.Osterreichische Zeitschrift Fur Onkologie. Austrian Journal of Oncology|January 1, 1977
Immunestimulation in cancer patients by a new synthetic compound: BM 06 002M Micksche, E M Kokoschka, O Kokron, et al.Zeitschrift Fur Rheumatologie|May 1, 1983
[Effects of therapy, serology, stage and activity of rheumatoid arthritis on lymphocyte stimulation in whole blood]U Fritze, D Fritze, U Bicker, et al.Diabetes Research (Edinburgh, Scotland)|March 1, 1987
Different effect of two immunomodulating agents cyclosporin A and ciamexon on the insulin metabolism of cultured mouse isletsT Linn, H Germann, R G Bretzel, et al.Pageof 4